NASDAQ : ICAD

iCAD, Inc.

$3.87 USD

$0.14 (3.75%)

Volume
190.13K
Average Volume
789.06K
Market Capitalization
$106.31M
P/E Ratio
-18.43
Dividend Yield
0.00%
Price Target
Year High
$4.01
Year Low
$1.19
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.50
Company Overview

NASDAQ

Dana R. Brown

Medical - Devices

Healthcare

ICAD

66

US

USD

https://www.icadmed.com

603 882 5200

44934S206

0000749660

Liquidity Metrics

0.01

3.50

3.40

2.28

0.00

Sales & Valuation

$19.61M

5.42

3.56

-25.85

-0.16

Profitability

-$0.21

-$5.62M

-28.64%

-28.14%

-18.09%

-14.96%

P/E Metrics

-18.43

0.29

0.29

Analyst Price Target & Rating

N/A

0/5

10 Analysts

%

Financial Health Scores

-1.86

3/9

$20.43M

$39.47M

$8.68M

-$5.42M

Key Metrics (TTM)

$89.47M

4.56

-18.33

3.50

-18.09%

-20.75%

-5.51%

-3.87%

91 days

Company Executives
Name Title
Jonathan Go Chief Technology Officer
Dana R. Brown President, Chief Executive Officer & Executive Chair
Michelle Strong Chief Operations Officer
Bill Keyes Senior Vice President of Global Sales Operations
Vasu Avadhanula Chief Product Officer
Eric Lonnqvist Chief Financial Officer
Peter Graham Senior Vice President of North American Sales
Mark Koeniguer Chief Commercial Officer
Brian Testa Chief People Officer
Annette L. Heroux Vice President of Administration
Poll Results

No votes yet today — be the first to share your view!

About iCAD, Inc. (NASDAQ:ICAD) Stock

iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While primarily operating in the United States, the company also maintains a significant international presence. Its operations are organized into two principal divisions: Cancer Detection and Cancer Therapy. In the Cancer Detection segment, iCAD provides a range of innovative technologies. This includes the PowerLook platform, which serves as a central host for artificial intelligence algorithms and facilitates seamless communication between imaging acquisition devices, storage systems, and review platforms. Key diagnostic offerings feature SecondLook, a machine learning-driven algorithm designed ... to examine 2D full-field digital mammography images for identifying and marking suspicious masses and calcifications. Additionally, the company offers automated solutions for consistent and standardized assessment of breast density. Its portfolio further extends to ProFound AI, a deep-learning algorithm adept at detecting malignant soft-tissue densities and calcifications within digital breast tomosynthesis, and ProFound AI Risk, a tool that provides breast cancer risk estimation derived from screening mammograms. Magnetic resonance imaging (MRI) applications are also available for detecting breast and prostate cancer, along with VeraLook, a solution supporting the identification of colonic polyps in conjunction with CT Colonography. The Cancer Therapy division features the Xoft Axxent electronic brachytherapy systems. These systems are employed in the treatment of early-stage breast, non-melanoma skin, and gynecological cancers. Their clientele is diverse, spanning university research centers, community hospitals, specialized cancer care clinics, veterinary facilities, and dermatology practices. iCAD distributes its products through multiple channels, utilizing its own direct sales organizations, as well as collaborating with original equipment manufacturer (OEM) partners, various distributors, technology platform partners, and resellers. The company also has a global footprint, exporting its advanced technologies to regions including Europe, Taiwan, Canada, China, and other international markets. Originally established in 1984 under the name Howtek, Inc., the company was rebranded as iCAD, Inc. in June 2002. Its corporate headquarters are located in Nashua, New Hampshire.

Frequently Asked Questions

What is the current iCAD, Inc. (ICAD) stock price?

iCAD, Inc.(NASDAQ:ICAD) stock price is $3.87 in the last trading session. During the trading session, ICAD stock reached the peak price of $4.01 while $1.19 was the lowest point it dropped to. The percentage change in ICAD stock occurred in the recent session was 3.75% while the dollar amount for the price change in ICAD stock was $0.14.

ICAD's industry and sector of operation?

The NASDAQ listed ICAD is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of ICAD?

Jonathan Go | Chief Technology Officer
Dana R. Brown | President, Chief Executive Officer & Executive Chair
Michelle Strong | Chief Operations Officer
Bill Keyes | Senior Vice President of Global Sales Operations
Vasu Avadhanula | Chief Product Officer

How many employees does ICAD have?

Number of ICAD employees currently stands at 66. ICAD operates from 98 Spit Brook Road, Nashua, NH 03062, US.

Link for ICAD official website?

Official Website of ICAD is: https://www.icadmed.com

How do I contact ICAD?

ICAD could be contacted at phone #603 882 5200 and can also be accessed through its website. ICAD operates from 98 Spit Brook Road, Nashua, NH 03062, US.

How many shares of ICAD are traded daily?

The average number of ICAD shares traded daily for last 3 months was 789.06K.

What is the market cap of ICAD currently?

The market value of ICAD currently stands at $106.31M with its latest stock price at $3.87